| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
GRH-SOMATOSTATIN-GH |
Laboratory of Neuroendocrinology of Aging, Centre Hospitalier de lUniversité Montréal Research Center, Notre Dame Hospital and Department of Medicine, University of Montréal, Montréal, Québec, Canada H2L 4M1; and Centre National de la Recherche Scientifique, UMR 5578, Université Claude Bernard Lyon I (G.M.), Villeurbanne 69622, France
Address all correspondence and requests for reprints to: Dr. Pierrette Gaudreau, Laboratory of Neuroendocrinology of Aging, Centre Hospitalier de lUniversité de Montréal Research Center, Notre Dame Hospital, Room M-5226, 1560 East Sherbrooke Street, Montréal, Québec, Canada H2L 4M1. E-mail: . pierrette.gaudreau{at}umontreal.ca
To provide information about the kidney GHRH receptor (GHRH-R), we assessed its tissue and cellular localization, defined its pattern of expression in developing and aging rats, and studied the effects of GHRH on the regulation of GHRH-R mRNA levels and receptor internalization. In situ hybridization and ribonuclease protection assay demonstrated that GHRH-R mRNA is restricted to the Henles loop (HL). GHRH-R mRNA levels were low in the medulla from 3- and 12-d-old male rats, increased significantly in that from 30- to 70-d-old rats, and decreased in that from 12- and 18-month-old animals. Compared with the GHRH-R mRNA profile obtained in the pituitary, these data support the concept of a tissue-specific regulation of GHRH-R. In HL cell cultures from 70-d-old rats, a 4-h incubation with 1100 nM rat GHRH-(129)NH2 reduced GHRH-R mRNA levels significantly. As anti-GHRH-R- (392404) immunoreactivity was demonstrated in HL cells, internalization of [N
-5-carboxyfluoresceinyl-D-Ala2,Ala8, Ala15,Lys22]hGHRH-(129)NH2 in a time- and temperature-dependent manner and inhibition of this process by phenyl arsine oxide indicate that desensitization to GHRH involves both GHRH-R internalization and down-regulation of GHRH-R mRNA levels. Localization of a functional GHRH-R in HL and its regulation during development and aging suggest roles associated with cellular proliferation, differentiation, and/or water/electrolyte transport.
This article has been cited by other articles:
![]() |
K. Bedard, J. Strecko, K. Theriault, J. Bedard, C. Veyrat-Durebex, and P. Gaudreau Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E740 - E751. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Rekasi, T. Czompoly, A. V. Schally, F. Boldizsar, J. L. Varga, M. Zarandi, T. Berki, R. A. Horvath, and P. Nemeth Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway PNAS, March 1, 2005; 102(9): 3435 - 3440. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kiaris, I. Chatzistamou, A. V. Schally, G. Halmos, J. L. Varga, H. Koutselini, and A. Kalofoutis Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor PNAS, August 5, 2003; 100(16): 9512 - 9517. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker International Union of Pharmacology. XXXV. The Glucagon Receptor Family Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |